Y0N3DA
Y0N3DA is a biotechnology company developing interventions to pause the aging process and enable the resurrection of deceased organs. Its research targets cellular and molecular mechanisms of age-related deterioration, aiming to extend tissue viability and restore function in organs previously considered non-viable for transplantation or therapeutic use.
- Biotechnology
- Drug Discovery & Therapeutics
- Healthcare Technology
Funding
Funding not disclosed
Founders
Founder details are not available yet.
Product
Problem
Age-related deterioration causes progressive loss of tissue and organ function, leading to chronic disease and eventual death. Organs that fail or become damaged are often deemed non-viable for transplantation, and current medical science lacks interventions to halt or reverse this decline.
Solution
Y0N3DA is a biotechnology company developing interventions to pause the aging process and enable the resurrection of deceased organs. Its research focuses on cellular and molecular mechanisms of age-related deterioration, aiming to extend tissue viability and restore function in organs previously considered non-viable for transplantation or therapeutic use. The company's approach targets the underlying biological processes that drive aging, with the goal of creating therapies that can preserve organ function and potentially revive organs after death.
Target Audience
Primary stakeholders include transplant medicine specialists, regenerative medicine researchers, and healthcare institutions seeking to expand the pool of viable donor organs and develop anti-aging therapies.
Features
- Research programs targeting cellular and molecular mechanisms of age-related deterioration
- Development of interventions to pause the aging process at the biological level
- Focus on extending tissue viability beyond current medical limits
- Approaches aimed at restoring function in deceased organs for potential transplantation or therapeutic use